Francisco Afrânio Cunha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francisco Afrânio Cunha has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Everardo Albuquerque Menezes
Universidade Federal do Ceará
8 shared publications - Antônio Alexandre de Vasconcelos Júnior
Universidade Federal do Ceará
7 shared publications Everardo Albuquerque Menezes
Universidade Federal do Ceará
6 shared publicationsMaria da Conceição dos Santos Oliveira Cunha
Universidade Federal do Ceará
4 shared publicationsCarlla Lorena Façanha Silva
UFCE
3 shared publications- Pierre Basílio Almeida Fechine
Federal University of Ceará Campus do Pici
3 shared publications
Latest Publications
- Open Access
- 22 August 2017
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 39 (2) , 129-131
In vitro synergistic activity of lidocaine and miconazole against Candida albicans
Candida albicans is the main yeast isolated from vulvovaginal candidiasis(VVC) and a major antifungal used to treat VVC is miconazole (MZ), it shows local toxic effects, such as irritation and burns. The lidocaine (LD) is a local anesthetic. The aim of this study was to evaluate the synergistic activity of LD/MZ against 19 strains of C. albicans isolated from vaginal secretion. 78.9% of the strains were susceptible to the combination LD/MZ, demonstrating synergism of drugs. These drugs can be used to produce vaginal creams to treat VVC, especially drug resistant.
- 22 August 2017
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 39 (2) , 129-131
Open AccessIn vitro synergistic activity of lidocaine and miconazole against Candida albicans
Candida albicans is the main yeast isolated from vulvovaginal candidiasis(VVC) and a major antifungal used to treat VVC is miconazole (MZ), it shows local toxic effects, such as irritation and burns. The lidocaine (LD) is a local anesthetic. The aim of this study was to evaluate the synergistic activity of LD/MZ against 19 strains of C. albicans isolated from vaginal secretion. 78.9% of the strains were susceptible to the combination LD/MZ, demonstrating synergism of drugs. These drugs can be used to produce vaginal creams to treat VVC, especially drug resistant.
- 17 May 2017
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 121 (21) , 11300-11311
Influence of Surface Silanization on the Physicochemical Stability of Silver Nanocoatings: A Large Length Scale Assessment
- 17 May 2017
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 121 (21) , 11300-11311
Influence of Surface Silanization on the Physicochemical Stability of Silver Nanocoatings: A Large Length Scale Assessment
- Open Access
- 1 January 2016
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 58, 73
SILVER NANOPARTICLES-DISK DIFFUSION TEST AGAINST Escherichia coli ISOLATES
Nanotechnology can be a valuable ally in the treatment of infections. Silver nanoparticles (AgNPs) are structures that have antimicrobial activity. The aim of this study was to produce AgNPs by green methods, characterize these structures, and assess their antimicrobial activity against Escherichia coli associated with the antibiotic ciprofloxacin. AgNPs were characterized by spectroscopic and microscopic techniques. Antimicrobial activity was evaluated by the disk diffusion method against 10 strains of E. coli. The synthesized AgNPs showed a spherical shape and a size of 85.07 ± 12.86 nm (mean ± SD). AgNPs increased the activity of ciprofloxacin by 40% and may represent a new therapeutic option for the treatment of bacterial infections.
- 1 January 2016
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 58, 73
Open AccessSILVER NANOPARTICLES-DISK DIFFUSION TEST AGAINST Escherichia coli ISOLATES
Nanotechnology can be a valuable ally in the treatment of infections. Silver nanoparticles (AgNPs) are structures that have antimicrobial activity. The aim of this study was to produce AgNPs by green methods, characterize these structures, and assess their antimicrobial activity against Escherichia coli associated with the antibiotic ciprofloxacin. AgNPs were characterized by spectroscopic and microscopic techniques. Antimicrobial activity was evaluated by the disk diffusion method against 10 strains of E. coli. The synthesized AgNPs showed a spherical shape and a size of 85.07 ± 12.86 nm (mean ± SD). AgNPs increased the activity of ciprofloxacin by 40% and may represent a new therapeutic option for the treatment of bacterial infections.
- Open Access
- 18 September 2015
- Published by BMJ in BMJ Case Reports
- Vol. 2015
An uncommon cause of portal hypertension
A 68-year-old woman with no history of hepatic disease or risk factors, with a 2-month duration of an increasing waist circumference and watery diarrhoea, as well as peripheral oedema, presented to the emergency department. The initial diagnostic work up revealed a large volume, high-gradient ascites, with a marked dilation of the splanchnic veins on angio-CT (figure 1). She was admitted for study and had a rapidly declining clinical status, with an episode of massive variceal …
- 18 September 2015
- Published by BMJ in BMJ Case Reports
- Vol. 2015
Open AccessAn uncommon cause of portal hypertension
A 68-year-old woman with no history of hepatic disease or risk factors, with a 2-month duration of an increasing waist circumference and watery diarrhoea, as well as peripheral oedema, presented to the emergency department. The initial diagnostic work up revealed a large volume, high-gradient ascites, with a marked dilation of the splanchnic veins on angio-CT (figure 1). She was admitted for study and had a rapidly declining clinical status, with an episode of massive variceal …
- Open Access
- 1 April 2015
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 57 (2) , 165-167
ANTIFUNGAL ACTIVITY OF SILVER NANOPARTICLES OBTAINED BY GREEN SYNTHESIS
Silver nanoparticles (AgNPs) are metal structures at the nanoscale. AgNPs have exhibited antimicrobial activities against fungi and bacteria; however synthesis of AgNPs can generate toxic waste during the reaction process. Accordingly, new routes using non-toxic compounds have been researched. The proposal of the present study was to synthesize AgNPs using ribose as a reducing agent and sodium dodecyl sulfate (SDS) as a stabilizer. The antifungal activity of these particles against C. albicans and C. tropicalis was also evaluated. Stable nanoparticles 12.5 ± 4.9 nm (mean ± SD) in size were obtained, which showed high activity against Candida spp. and could represent an alternative for fungal infection treatment.
- 1 April 2015
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 57 (2) , 165-167
Open AccessANTIFUNGAL ACTIVITY OF SILVER NANOPARTICLES OBTAINED BY GREEN SYNTHESIS
Silver nanoparticles (AgNPs) are metal structures at the nanoscale. AgNPs have exhibited antimicrobial activities against fungi and bacteria; however synthesis of AgNPs can generate toxic waste during the reaction process. Accordingly, new routes using non-toxic compounds have been researched. The proposal of the present study was to synthesize AgNPs using ribose as a reducing agent and sodium dodecyl sulfate (SDS) as a stabilizer. The antifungal activity of these particles against C. albicans and C. tropicalis was also evaluated. Stable nanoparticles 12.5 ± 4.9 nm (mean ± SD) in size were obtained, which showed high activity against Candida spp. and could represent an alternative for fungal infection treatment.
- Open Access
- 1 February 2013
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 46 (1) , 106-107
Correlation between microdilution, Etest, and disk diffusion methods for antifungal susceptibility testing of fluconazole against Candida sp. blood isolates
Key words: Disk diffusion; Antifungal susceptibility; Fluconazole
- 1 February 2013
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 46 (1) , 106-107
Open AccessCorrelation between microdilution, Etest, and disk diffusion methods for antifungal susceptibility testing of fluconazole against Candida sp. blood isolates
Key words: Disk diffusion; Antifungal susceptibility; Fluconazole
- 21 January 2013
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 25 (2) , 138-142
Antifungal activity and mode of action of carvacrol againstCandida albicansstrains
In this study, the minimal inhibitory concentration (MIC), minimal fungicidal concentration (MFC) and mode of action of carvacrol were determined. MIC was determined according to the standard broth microdilution method, and MFC was taken as the lowest concentration in culture plates with Sabouraud dextrose agar, at which growth was less than 3 CFU. The effect of ergosterol or sorbitol on carvacrol was investigated using the broth microdilution method. MIC was 256 μg/mL and MFC was 512 μg/mL. This phytoconstituent acts by binding to sterols in the fungal membrane and does not act by modifying the fungal cell wall. This study is important because it shows the mode of action of carvacrol. However, more studies are necessary to define the exact mechanism of action.
- 21 January 2013
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 25 (2) , 138-142
Antifungal activity and mode of action of carvacrol againstCandida albicansstrains
In this study, the minimal inhibitory concentration (MIC), minimal fungicidal concentration (MFC) and mode of action of carvacrol were determined. MIC was determined according to the standard broth microdilution method, and MFC was taken as the lowest concentration in culture plates with Sabouraud dextrose agar, at which growth was less than 3 CFU. The effect of ergosterol or sorbitol on carvacrol was investigated using the broth microdilution method. MIC was 256 μg/mL and MFC was 512 μg/mL. This phytoconstituent acts by binding to sterols in the fungal membrane and does not act by modifying the fungal cell wall. This study is important because it shows the mode of action of carvacrol. However, more studies are necessary to define the exact mechanism of action.
- Open Access
- 1 December 2012
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Patologia e Medicina Laboratorial
- Vol. 48 (6) , 415-420
Identificação molecular e suscetibilidade antifúngica de Candida parapsilosis isoladas no Ceará, Brasil
- 1 December 2012
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Patologia e Medicina Laboratorial
- Vol. 48 (6) , 415-420
Open AccessIdentificação molecular e suscetibilidade antifúngica de Candida parapsilosis isoladas no Ceará, Brasil
- Open Access
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 54 (4) , 197-199
In vitro synergism of simvastatin and fluconazole against Candida species
Systemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed according to protocol M27-A3, by broth microdilution method and the synergistic effect of simvastatin and fluconazole was calculated based on FICI (Fractional Inhibitory Concentration Index). Eleven strains were evaluated, and simvastatin showed a synergistic effect with fluconazole against 10 (91%) of the Candida spp. strains tested. Simvastatin may be a valuable drug in the treatment of systemic infections caused by Candida spp.
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 54 (4) , 197-199
Open AccessIn vitro synergism of simvastatin and fluconazole against Candida species
Systemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed according to protocol M27-A3, by broth microdilution method and the synergistic effect of simvastatin and fluconazole was calculated based on FICI (Fractional Inhibitory Concentration Index). Eleven strains were evaluated, and simvastatin showed a synergistic effect with fluconazole against 10 (91%) of the Candida spp. strains tested. Simvastatin may be a valuable drug in the treatment of systemic infections caused by Candida spp.